PTC Inc. (PTC) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this product development software maker would post earnings of $0.98 per share when it actually produced earnings of $0.98, delivering no surprise.Over the last four quarters, the ...

Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal YearBOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024."In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages our unique portfolio to help product companies accelerate their time to mark ...

BOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC common stock through September 30, 2027."This repurchase authorization demonstrates the Board's confidence in PTC's ability to drive customer value while enhancing shareholder returns, and supports PTC's capital allocation strategy," said Janice Chaffin, Chair of the Board."PTC intends to repurchase approximately $300 million of our common stock in ...

EX 99.1 PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal Year BOSTON, MA, November 6, 2024 - PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024. "In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages ou ...

文章核心观点 - PTC公司预计第四季度收入将在5.98亿美元至6.48亿美元之间,非GAAP每股收益预计在1.30美元至1.66美元之间 [1][2] - 公司的CAD和PLM解决方案业务持续成为主要收入驱动因素,有望支撑本季度表现 [3] - 公司的SLM和ALM解决方案的采用增加也可能带来额外的推动力 [4] - 公司在物联网、增强现实和人工智能等新兴技术的投资与行业趋势相符 [4] - 订阅模式转型和提高运营纪律有助于推动现金流 [5] 财务数据总结 - 第四季度预计年度经常性收入(ARR)在22亿美元至22.2亿美元之间 [5] - 第四季度预计经营活动现金流为8800万美元,自由现金流为8300万美元 [5] - 2024财年ARR预计增长11-12%,达到22亿-22.2亿美元 [5] - 2024财年收入预计增长8-11%,达到22.7亿-23.2亿美元 [5] 行业趋势和挑战 - 不利的汇率变动和疲软的需求环境可能成为阻碍 [6] - 为应对CAD和PLM领域激烈竞争而增加的研发成本可能会影响利润表现 [6]

Wall Street analysts forecast that PTC Inc. (PTC) will report quarterly earnings of $1.43 per share in its upcoming release, pointing to a year-over-year increase of 19.2%. It is anticipated that revenues will amount to $620.49 million, exhibiting an increase of 13.5% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed ...

Wall Street expects a year-over-year increase in earnings on higher revenues when PTC Inc. (PTC) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better than ex ...

MALVERN, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of inrush current limiting positive temperature coefficient (PTC) thermistors. Designed to increase performance in active charge and discharge circuits for automotive and industrial applications, Vishay BCcomponents PTCEL High Energy series devices combine maximum energy handling to 340 J — five times higher than competing devices at high ambient temperatures — with a wide range of resistan ...

WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). "The NDA acceptance for review is a significant milestone that brings us one step closer to providing this important treatment to boys and young men living with nonsense mutation Duchenne musc ...

WARREN, N.J., Oct. 24, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its third quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Nov. 7, at 4:30 p.m. EST.To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of ...